PA
RMD icon

Paralel Advisors’s ResMed RMD Stock Holding History

Paralel Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
+10,293
New +$2.13M 0.08% 98

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Paralel Advisors's RMD Position: Q2 2026 in Review

Paralel Advisors opened a new position in ResMed (RMD) in Q2 2026: 10,293 shares worth $2.01M. The stake represents 0.08% of the portfolio and ranks #98 among its holdings.

882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Paralel Advisors held 10,293 shares of ResMed worth $2.01M as of Q2 2026.
  • ResMed was a new Paralel Advisors position in Q2 2026.
  • ResMed made up 0.08% of Paralel Advisors's portfolio in Q2 2026, its #98 holding.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.